GRIFOLS SA-ADR (GRFS) Stock Fundamental Analysis
USA - NASDAQ:GRFS - US3984384087 - ADR
9.335 USD
-0.02 (-0.27%)
GRFS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 534 industry peers in the Biotechnology industry. GRFS scores excellent on profitability, but there are some minor concerns on its financial health. GRFS scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
GRFS had positive earnings in the past year.
GRFS had a positive operating cash flow in the past year.
GRFS had positive earnings in each of the past 5 years.
In multiple years GRFS reported negative operating cash flow during the last 5 years.
1.2 Ratios
With an excellent Return On Assets value of 1.50%, GRFS belongs to the best of the industry, outperforming 89.89% of the companies in the same industry.
GRFS's Return On Equity of 5.75% is amongst the best of the industry. GRFS outperforms 92.13% of its industry peers.
The Return On Invested Capital of GRFS (4.79%) is better than 92.51% of its industry peers.
GRFS had an Average Return On Invested Capital over the past 3 years of 2.90%. This is significantly below the industry average of 15.49%.
The last Return On Invested Capital (4.79%) for GRFS is above the 3 year average (2.90%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.5% | ||
| ROE | 5.75% | ||
| ROIC | 4.79% |
ROA(3y)0.66%
ROA(5y)1.4%
ROE(3y)2.39%
ROE(5y)4.54%
ROIC(3y)2.9%
ROIC(5y)3.1%
1.3 Margins
With an excellent Profit Margin value of 3.99%, GRFS belongs to the best of the industry, outperforming 90.82% of the companies in the same industry.
In the last couple of years the Profit Margin of GRFS has declined.
Looking at the Operating Margin, with a value of 17.80%, GRFS belongs to the top of the industry, outperforming 93.82% of the companies in the same industry.
GRFS's Operating Margin has declined in the last couple of years.
GRFS has a Gross Margin of 39.37%. This is in the better half of the industry: GRFS outperforms 74.16% of its industry peers.
In the last couple of years the Gross Margin of GRFS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.8% | ||
| PM (TTM) | 3.99% | ||
| GM | 39.37% |
OM growth 3Y11.99%
OM growth 5Y-6.16%
PM growth 3Y-17.15%
PM growth 5Y-29.24%
GM growth 3Y-0.88%
GM growth 5Y-3.34%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GRFS is destroying value.
The number of shares outstanding for GRFS remains at a similar level compared to 1 year ago.
The number of shares outstanding for GRFS remains at a similar level compared to 5 years ago.
GRFS has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.33, we must say that GRFS is in the distress zone and has some risk of bankruptcy.
GRFS has a better Altman-Z score (1.33) than 62.55% of its industry peers.
GRFS has a debt to FCF ratio of 13.86. This is a negative value and a sign of low solvency as GRFS would need 13.86 years to pay back of all of its debts.
GRFS has a Debt to FCF ratio of 13.86. This is amongst the best in the industry. GRFS outperforms 91.20% of its industry peers.
GRFS has a Debt/Equity ratio of 1.76. This is a high value indicating a heavy dependency on external financing.
GRFS has a Debt to Equity ratio of 1.76. This is in the lower half of the industry: GRFS underperforms 79.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.76 | ||
| Debt/FCF | 13.86 | ||
| Altman-Z | 1.33 |
ROIC/WACC0.91
WACC5.28%
2.3 Liquidity
GRFS has a Current Ratio of 2.64. This indicates that GRFS is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of GRFS (2.64) is worse than 67.98% of its industry peers.
A Quick Ratio of 0.95 indicates that GRFS may have some problems paying its short term obligations.
With a Quick ratio value of 0.95, GRFS is not doing good in the industry: 87.08% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.64 | ||
| Quick Ratio | 0.95 |
3. Growth
3.1 Past
GRFS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 110.19%, which is quite impressive.
The earnings per share for GRFS have been decreasing by -23.99% on average. This is quite bad
Looking at the last year, GRFS shows a quite strong growth in Revenue. The Revenue has grown by 9.32% in the last year.
GRFS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.18% yearly.
EPS 1Y (TTM)110.19%
EPS 3Y-6.22%
EPS 5Y-23.99%
EPS Q2Q%760.5%
Revenue 1Y (TTM)9.32%
Revenue growth 3Y13.5%
Revenue growth 5Y7.18%
Sales Q2Q%102.26%
3.2 Future
GRFS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.95% yearly.
GRFS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.37% yearly.
EPS Next Y46.39%
EPS Next 2Y37.18%
EPS Next 3Y32.5%
EPS Next 5Y23.95%
Revenue Next Year5.46%
Revenue Next 2Y6.08%
Revenue Next 3Y6.4%
Revenue Next 5Y6.37%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
GRFS is valuated rather expensively with a Price/Earnings ratio of 18.30.
Compared to the rest of the industry, the Price/Earnings ratio of GRFS indicates a rather cheap valuation: GRFS is cheaper than 95.69% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.00. GRFS is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 7.75, the valuation of GRFS can be described as very cheap.
GRFS's Price/Forward Earnings ratio is rather cheap when compared to the industry. GRFS is cheaper than 98.13% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.87, GRFS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.3 | ||
| Fwd PE | 7.75 |
4.2 Price Multiples
97.38% of the companies in the same industry are more expensive than GRFS, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, GRFS is valued cheaper than 98.69% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.85 | ||
| EV/EBITDA | 7.96 |
4.3 Compensation for Growth
GRFS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GRFS has a very decent profitability rating, which may justify a higher PE ratio.
GRFS's earnings are expected to grow with 32.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.39
PEG (5Y)N/A
EPS Next 2Y37.18%
EPS Next 3Y32.5%
5. Dividend
5.1 Amount
GRFS has a Yearly Dividend Yield of 4.29%, which is a nice return.
GRFS's Dividend Yield is rather good when compared to the industry average which is at 88.06. GRFS pays more dividend than 99.25% of the companies in the same industry.
GRFS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.29% |
5.2 History
The dividend of GRFS decreases each year by -66.87%.
GRFS has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-66.87%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y37.18%
EPS Next 3Y32.5%
NASDAQ:GRFS (10/29/2025, 11:48:01 AM)
9.335
-0.02 (-0.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners30.45%
Inst Owner Change0.06%
Ins Owners6.36%
Ins Owner ChangeN/A
Market Cap6.35B
Revenue(TTM)7.45B
Net Income(TTM)297.45M
Analysts74.74
Price Target13.67 (46.44%)
Short Float %2.06%
Short Ratio10.95
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.29% |
Yearly Dividend0
Dividend Growth(5Y)-66.87%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.84%
PT rev (3m)6.36%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)2.86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-1.57%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.3 | ||
| Fwd PE | 7.75 | ||
| P/S | 0.73 | ||
| P/FCF | 7.85 | ||
| P/OCF | 4.94 | ||
| P/B | 1.06 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.96 |
EPS(TTM)0.51
EY5.46%
EPS(NY)1.2
Fwd EY12.9%
FCF(TTM)1.19
FCFY12.74%
OCF(TTM)1.89
OCFY20.23%
SpS12.72
BVpS8.83
TBVpS-9.18
PEG (NY)0.39
PEG (5Y)N/A
Graham Number10.07
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.5% | ||
| ROE | 5.75% | ||
| ROCE | 7.45% | ||
| ROIC | 4.79% | ||
| ROICexc | 5.02% | ||
| ROICexgc | 13.28% | ||
| OM | 17.8% | ||
| PM (TTM) | 3.99% | ||
| GM | 39.37% | ||
| FCFM | 9.34% |
ROA(3y)0.66%
ROA(5y)1.4%
ROE(3y)2.39%
ROE(5y)4.54%
ROIC(3y)2.9%
ROIC(5y)3.1%
ROICexc(3y)3.07%
ROICexc(5y)3.33%
ROICexgc(3y)6.89%
ROICexgc(5y)7.47%
ROCE(3y)4.51%
ROCE(5y)4.82%
ROICexgc growth 3Y11.6%
ROICexgc growth 5Y-8.62%
ROICexc growth 3Y14.21%
ROICexc growth 5Y-7.74%
OM growth 3Y11.99%
OM growth 5Y-6.16%
PM growth 3Y-17.15%
PM growth 5Y-29.24%
GM growth 3Y-0.88%
GM growth 5Y-3.34%
F-Score8
Asset Turnover0.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.76 | ||
| Debt/FCF | 13.86 | ||
| Debt/EBITDA | 5.17 | ||
| Cap/Depr | 93.6% | ||
| Cap/Sales | 5.5% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 62.7% | ||
| Profit Quality | 233.89% | ||
| Current Ratio | 2.64 | ||
| Quick Ratio | 0.95 | ||
| Altman-Z | 1.33 |
F-Score8
WACC5.28%
ROIC/WACC0.91
Cap/Depr(3y)62.1%
Cap/Depr(5y)77.33%
Cap/Sales(3y)1.39%
Cap/Sales(5y)3.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)110.19%
EPS 3Y-6.22%
EPS 5Y-23.99%
EPS Q2Q%760.5%
EPS Next Y46.39%
EPS Next 2Y37.18%
EPS Next 3Y32.5%
EPS Next 5Y23.95%
Revenue 1Y (TTM)9.32%
Revenue growth 3Y13.5%
Revenue growth 5Y7.18%
Sales Q2Q%102.26%
Revenue Next Year5.46%
Revenue Next 2Y6.08%
Revenue Next 3Y6.4%
Revenue Next 5Y6.37%
EBIT growth 1Y44.14%
EBIT growth 3Y27.11%
EBIT growth 5Y0.58%
EBIT Next Year47.43%
EBIT Next 3Y22.74%
EBIT Next 5Y16.15%
FCF growth 1Y239.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y883.42%
OCF growth 3YN/A
OCF growth 5YN/A
GRIFOLS SA-ADR / GRFS FAQ
Can you provide the ChartMill fundamental rating for GRIFOLS SA-ADR?
ChartMill assigns a fundamental rating of 6 / 10 to GRFS.
What is the valuation status for GRFS stock?
ChartMill assigns a valuation rating of 9 / 10 to GRIFOLS SA-ADR (GRFS). This can be considered as Undervalued.
What is the profitability of GRFS stock?
GRIFOLS SA-ADR (GRFS) has a profitability rating of 7 / 10.
Can you provide the expected EPS growth for GRFS stock?
The Earnings per Share (EPS) of GRIFOLS SA-ADR (GRFS) is expected to grow by 46.39% in the next year.
Can you provide the dividend sustainability for GRFS stock?
The dividend rating of GRIFOLS SA-ADR (GRFS) is 5 / 10 and the dividend payout ratio is 0%.